Journal article · 2003 · Open access

B cells as a therapeutic target in autoimmune disease.

Jörg J. Goronzy, Cornelia M. Weyand

Arthritis Research, 5(3), 131 · Published 1 January 2003 · DOI 10.1186/ar751

Open PDFView at the publisherCite this paper

In brief

“B cells as a therapeutic target in autoimmune disease.” is a 2003 journal article by Jörg J. Goronzy and Cornelia M. Weyand, published in Arthritis Research. OpenAlex counts 20 citations as of 20 November 2026. It is open access: the full text is free to read at Arthritis Research.

Citations
20
Most cited in
2013 (2)
Field-weighted impact
1.74
References
42
Authors
2

Abstract

Depleting B cells with anti-CD20 monoclonal antibodies emerges as a new therapeutic strategy in autoimmune diseases. Preliminary clinical studies suggest therapeutic benefits in patients with classic autoantibody-mediated syndromes, such as autoimmune cytopenias. Treatment responses in rheumatoid arthritis have opened the discussion about whether mechanisms beyond the removal of potentially pathogenic antibodies are effective in B-cell depletion. B cells may modulate T-cell activity through capturing and presenting antigens or may participate in the neogenesis of lymphoid microstructures that amplify and deviate immune responses. Studies exploring which mechanisms are functional in which subset of patients hold the promise of providing new and rational treatment approaches for autoimmune syndromes.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Goronzy, J. J., & Weyand, C. M. (2003). B cells as a therapeutic target in autoimmune disease. Arthritis Research, 5(3), 131. https://doi.org/10.1186/ar751

MLA 9

Goronzy, Jörg J., and Cornelia M. Weyand. “B cells as a therapeutic target in autoimmune disease.” Arthritis Research, vol. 5, no. 3, 2003, p. 131. https://doi.org/10.1186/ar751.

Chicago

Goronzy, Jörg J. and Cornelia M. Weyand. 2003. “B cells as a therapeutic target in autoimmune disease.” Arthritis Research 5 (3): 131. https://doi.org/10.1186/ar751.

Harvard

Goronzy, J. J. and Weyand, C. M. (2003) ‘B cells as a therapeutic target in autoimmune disease.’, Arthritis Research, 5(3), p. 131. doi:10.1186/ar751.

IEEE

J. J. Goronzy and C. M. Weyand, “B cells as a therapeutic target in autoimmune disease.,” Arthritis Research, vol. 5, no. 3, p. 131, 2003, doi: 10.1186/ar751.

BibTeX

@article{goronzy2003cells,
  title     = {{B cells as a therapeutic target in autoimmune disease.}},
  author    = {Goronzy, Jörg J. and Weyand, Cornelia M.},
  journal   = {Arthritis Research},
  year      = {2003},
  volume    = {5},
  number    = {3},
  pages     = {131},
  doi       = {10.1186/ar751},
  url       = {https://doi.org/10.1186/ar751}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201322
201611
201911

Its field-weighted citation impact is 1.74: it has been cited 1.74 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies

  • B cells
  • B-cell depletion
  • anti-CD20 monoclonal antibody
  • autoimmune disease
  • rheumatoid arthritis
  • autoimmune cytopenia
  • autoantibodies
  • T cell regulation

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Goronzy, J. J., & Weyand, C. M. (2003). B cells as a therapeutic target in autoimmune disease. Arthritis Research, 5(3), 131. https://doi.org/10.1186/ar751

How many times has this paper been cited?

20 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Arthritis Research: sign in and open the PDF from this page.

Who wrote this paper?

Jörg J. Goronzy, Cornelia M. Weyand.

What is the DOI of this paper?

10.1186/ar751, permanently at https://doi.org/10.1186/ar751. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.